Q.13 In N-linked glycosylation, the oligosaccharide chain is attached to protein by (A) asparagine (B) arginine (C) serine (D) threonine

Q.13 In N-linked glycosylation, the oligosaccharide chain is attached to protein by

  • (A) asparagine
  • (B) arginine
  • (C) serine
  • (D) threonine

    In N-linked glycosylation, the oligosaccharide chain attaches to the asparagine residue of proteins via an N-glycosidic bond in the ER. This SEO-optimized article answers the MCQ: In N-linked glycosylation, the oligosaccharide chain is attached to protein by (A) asparagine, (B) arginine, (C) serine, (D) threonine—essential for biochemistry, biotechnology, and mammalian cell culture students.

    Correct Answer: Option (A) Asparagine

    N-linked glycosylation links pre-assembled Glc3Man9GlcNAc2 oligosaccharides from dolichol pyrophosphate to asparagine in the consensus sequence Asn-X-Ser/Thr (X ≠ Pro), catalyzed by oligosaccharyltransferase (OST) co-translationally.

    This modification drives protein folding (calnexin cycle), quality control, and trafficking in your mammalian cell culture research, with ~1-25% of eukaryotic proteins glycosylated.

    Explanation of All Options

    N- vs O-glycosylation targets different amino acid side chains:

    • (A) Asparagine: Correct. N-glycosylation forms amide bond with Asn’s side-chain nitrogen in ER lumen.

    • (B) Arginine: Incorrect. No glycosylation occurs; arginine’s guanidinium supports protein-protein interactions.

    • (C) Serine: Incorrect. O-GalNAc glycosylation target (mucin-type) in Golgi, not N-linked.

    • (D) Threonine: Incorrect. Also O-linked target with Ser, forming O-glycosidic bonds post-translationally.

    Option Amino Acid Glycosylation Type Bond Formed Correct/Incorrect
    (A) Asparagine Asn N-linked N-glycosidic (amide) Correct 
    (B) Arginine Arg None N/A Incorrect
    (C) Serine Ser O-linked (Golgi) O-glycosidic Incorrect
    (D) Threonine Thr O-linked (Golgi) O-glycosidic Incorrect 

    Biotechnology Relevance

    Proper N-glycosylation in CHO cells ensures therapeutic efficacy (e.g., tPA folding/stability from Q.5), directly impacting your animal cell culture and enzyme kinetics work. Defects cause congenital disorders of glycosylation (CDG).

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest Courses